Trial Profile
InductOs in Real World Spine Surgery; A Retrospective, French, Multi-centric, Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2023
Price :
$35
*
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Spinal disorders
- Focus Therapeutic Use
- Acronyms InductOR
- Sponsors Medtronic
- 17 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 13 Oct 2015 Planned end date changed from 1 Aug 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 13 Oct 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.